Abstract OT3-1-06: CIBOMA/2004-01GEICAM/2003-11: A randomised phase III trial assessing adjuvant capecitabine (Cap) maintenance therapy after standard chemotherapy for triple-negative early breast cancer (EBC) | Publicación